English | 简体中文 | 繁體中文 | 한국어 | 日本語
Monday, 23 September 2019, 08:00 HKT/SGT
Share:
    

Source: Woodbridge
Woodbridge Buys-Out Joint Venture Partner in China to Enhance Regional Growth Opportunities

TROY, MI, Sept 23, 2019 - (ACN Newswire) - Woodbridge, a global systems solution provider of fully-integrated foam products, announces it has entered into a formal agreement to acquire all the shares in its joint venture, Woodbridge GSK High Polymer Technology Co., Ltd. (WGSK), from its partner GSK Corporation. The transaction will enable Woodbridge to enhance its growth opportunities with its customers located in China.

Upon regulatory approval, GSK's shares will be transferred to Woodbridge. The acquisition includes molded foam manufacturing operations in China: Wuhan (WGSK), Guangzhou (Guangzhou Woodbridge GSK High Polymer Technology Co., Ltd.) and Shanghai (Shanghai Woodbridge GSK Auto Parts Co., Ltd.).

"Woodbridge has been the management partner and technology provider of these three sites for 14 years," said Woodbridge president and CEO Charles Daly. "These facilities will allow our technical expertise, operational excellence and proven track record to continue to be a powerful platform to accelerate growth within the region."

According to Greg Yan, Woodbridge general manager, China, "On behalf of the entire team, I would like to thank GSK for their partnership and wish them continued success. Today marks an exciting chapter for us and reflects the collective efforts of our entire team and we look forward to our future in China."

Following the completion of the sale, Woodbridge will continue to supply molded foam to GSK's seat assembly operations.

About Woodbridge

Woodbridge is a privately-owned company offering innovative material technologies for applications in automotive, commercial, recreational, packaging, healthcare and building products. In addition to its manufacturing operations, Woodbridge offers a full complement of services including: chemical research and development, product and process engineering, tooling, technical support and accredited laboratory testing. Woodbridge operates more than 60 facilities across 10 countries-employing over 7,500 teammates and serving more than 600 customers worldwide. To learn more, visit woodbridgegroup.com.

Media Contacts:
Eric Turmel, Marketing Manager
(248) 280-6322
[email protected]

Greg Yan, General Manager, China
011-86-21-3173-5912, ext. 6522
[email protected]

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/48006

Topic: Press release summary
Sectors: Chemicals, Alternatives, Venture Capital
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2020 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
AbbVie and Eisai Announce an Approval for Partial Changes in the Marketing Approval of HUMIRA, a Fully Human Anti-TNFalpha Monoclonal Antibody  
May 29, 2020 14:54 HKT/SGT
Sharp Releases Notice of Corporate Spin-Off of the Display Device Business Division  
May 29, 2020 14:47 HKT/SGT
DENSO Announces Changes in the Areas of Responsibility of Senior Executive Officers and Executive Officers  
May 29, 2020 11:05 HKT/SGT
Eisai: Results from LENVIMA (lenvatinib) plus KEYTRUDA (pembrolizumab) Trials   
May 29, 2020 10:31 HKT/SGT
Paice, Abell, and Daimler Agree to License Patented Technology  
May 29, 2020 06:00 HKT/SGT
Sino Biopharmaceutical Announces 2020 First Quarterly Results  
May 28, 2020 19:59 HKT/SGT
Hitachi Announces Change in the Effective Date for Company Split and Closing Date of Share Transfer  
May 28, 2020 18:18 HKT/SGT
Mitsubishi Motors Announces Production, Sales and Export Figures for April 2020  
May 28, 2020 18:09 HKT/SGT
Honda Sets Monthly Records for Automobile Production in China  
May 28, 2020 17:52 HKT/SGT
Mazda Production and Sales Results for April 2020  
May 28, 2020 15:46 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2020 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6653 1210 | Tokyo: +81 3 6859 8575